Yahoo Poland Wyszukiwanie w Internecie

Search results

1. www.pfizer.com › pfizer-biontech-covid-19-vaccine-comirnatyr-receives-fullPfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S....

   www.pfizer.com › pfizer-biontech-covid-19-vaccine-comirnatyr-receives-full

   • Zapisane w pamięci cache

   11 gru 2020 · COMIRNATY ® (COVID-19 Vaccine, mRNA) is an FDA-approved COVID-19 vaccine made by Pfizer for BioNTech. It is approved as a 2-dose series for prevention of COVID-19 in individuals 16 years of age and older; It is also authorized under Emergency Use Authorization (EUA) to be administered for emergency use to:

   • View PDF

     The Pfizer-BioNTech COVID-19 Vaccine has received EUA from...

   • Vaccines Manufacturing B-roll Video

     This information—including product information—is intended...

2. www.ema.europa.eu › en › newsComirnaty and Spikevax: EMA recommendations on extra doses and...

   www.ema.europa.eu › en › news

   • Zapisane w pamięci cache

   4 paź 2021 · EMA’s human medicines committee (CHMP) has concluded that an extra dose of the COVID-19 vaccines Comirnaty (BioNTech/Pfizer) and Spikevax (Moderna) may be given to people with severely weakened immune systems, at least 28 days after their second dose.

3. www.cdc.gov › vaccines › phpPfizer COVID-19 Vaccine Summary | Vaccines & Immunizations | CDC

   www.cdc.gov › vaccines › php

   • Zapisane w pamięci cache

   28 sie 2024 · Pfizer-BioNTech COVID-19 Vaccine is indicated for individuals 5 through 11 years of age (via a 10mcg / 0.3mL single-dose vial presentation) and for individuals 6 months through 4 years of age (via a 3mcg / 0.3mL multi-dose vial (3 doses per vial) presentation).

4. www.fda.gov › news-events › press-announcementsFDA Approves and Authorizes Updated mRNA COVID-19 Vaccines to...

   www.fda.gov › news-events › press-announcements

   • Zapisane w pamięci cache

   22 sie 2024 · Individuals 12 years of age and older are eligible to receive a single dose of the updated, approved Comirnaty or the updated, approved Spikevax; if previously vaccinated, the dose is...

5. labeling.pfizer.com › ShowLabelingVACCINE INFORMATION FACT SHEET FOR RECIPIENTS AND CAREGIVERS ......

   labeling.pfizer.com › ShowLabeling

   COMIRNATY (COVID-19 Vaccine, mRNA) and the Pfizer-BioNTech COVID-19 Vaccine have been shown to prevent COVID-19. FDA has authorized Pfizer-BioNTech COVID-19 Vaccine, Bivalent to provide better protection against COVID-19 caused by the Omicron variant of SARS-CoV-2.

6. www.ema.europa.eu › en › newsFirst adapted COVID-19 booster vaccines recommended for approval...

   www.ema.europa.eu › en › news

   • Zapisane w pamięci cache

   1 wrz 2022 · News. First adapted COVID-19 booster vaccines recommended for approval in the EU. 1 September 2022. News Human COVID-19 Vaccines. The adapted COVID-19 vaccines Comirnaty Original/Omicron BA.1 and Spikevax bivalent Original/Omicron BA.1 are now authorised across the EU. This follows a decision from the European Commission issued on 1 September 2022.

7. www.fda.gov › media › 167212FACT SHEET FOR RECIPIENTS AND CAREGIVERS ABOUT PFIZER-BIONTECH...

   www.fda.gov › media › 167212

   22 sie 2024 · COMIRNATY is an FDA-approved vaccine for prevention of COVID-19 in individuals 12 years of age and older that is authorized under EUA to complete the dosing schedule for immunocompromised...